chr18-59431510-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133459.4(CCBE1):​c.*4398C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.831 in 152,098 control chromosomes in the GnomAD database, including 52,636 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.83 ( 52624 hom., cov: 31)
Exomes 𝑓: 0.96 ( 12 hom. )

Consequence

CCBE1
NM_133459.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.744

Publications

2 publications found
Variant links:
Genes affected
CCBE1 (HGNC:29426): (collagen and calcium binding EGF domains 1) This gene is thought to function in extracellular matrix remodeling and migration. It is predominantly expressed in the ovary, but down regulated in ovarian cancer cell lines and primary carcinomas, suggesting its role as a tumour suppressor. Mutations in this gene have been associated with Hennekam lymphangiectasia-lymphedema syndrome, a generalized lymphatic dysplasia in humans. [provided by RefSeq, Mar 2010]
CCBE1 Gene-Disease associations (from GenCC):
  • Hennekam lymphangiectasia-lymphedema syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • Hennekam syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 18-59431510-G-T is Benign according to our data. Variant chr18-59431510-G-T is described in ClinVar as Benign. ClinVar VariationId is 327597.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.887 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_133459.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
NM_133459.4
MANE Select
c.*4398C>A
3_prime_UTR
Exon 11 of 11NP_597716.1Q6UXH8-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCBE1
ENST00000439986.9
TSL:1 MANE Select
c.*4398C>A
3_prime_UTR
Exon 11 of 11ENSP00000404464.2Q6UXH8-1
CCBE1
ENST00000649564.1
c.*4398C>A
3_prime_UTR
Exon 12 of 12ENSP00000497183.1Q6UXH8-1
CCBE1
ENST00000650467.2
c.*4398C>A
3_prime_UTR
Exon 9 of 9ENSP00000496897.2A0A3B3IRL6

Frequencies

GnomAD3 genomes
AF:
0.831
AC:
126252
AN:
151954
Hom.:
52584
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.890
Gnomad AMI
AF:
0.812
Gnomad AMR
AF:
0.803
Gnomad ASJ
AF:
0.815
Gnomad EAS
AF:
0.883
Gnomad SAS
AF:
0.910
Gnomad FIN
AF:
0.761
Gnomad MID
AF:
0.850
Gnomad NFE
AF:
0.804
Gnomad OTH
AF:
0.809
GnomAD4 exome
AF:
0.962
AC:
25
AN:
26
Hom.:
12
Cov.:
0
AF XY:
0.938
AC XY:
15
AN XY:
16
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
4
AN:
4
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.950
AC:
19
AN:
20
Other (OTH)
AF:
1.00
AC:
2
AN:
2
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.831
AC:
126350
AN:
152072
Hom.:
52624
Cov.:
31
AF XY:
0.829
AC XY:
61581
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.890
AC:
36941
AN:
41494
American (AMR)
AF:
0.803
AC:
12265
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.815
AC:
2828
AN:
3472
East Asian (EAS)
AF:
0.883
AC:
4554
AN:
5160
South Asian (SAS)
AF:
0.909
AC:
4379
AN:
4816
European-Finnish (FIN)
AF:
0.761
AC:
8022
AN:
10542
Middle Eastern (MID)
AF:
0.849
AC:
248
AN:
292
European-Non Finnish (NFE)
AF:
0.804
AC:
54663
AN:
68002
Other (OTH)
AF:
0.811
AC:
1711
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1094
2188
3282
4376
5470
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
888
1776
2664
3552
4440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.800
Hom.:
3196
Bravo
AF:
0.833
Asia WGS
AF:
0.893
AC:
3106
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Hennekam lymphangiectasia-lymphedema syndrome 1 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.17
DANN
Benign
0.38
PhyloP100
-0.74
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6567083; hg19: chr18-57098742; API